| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.081 | 0.2 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.2 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.3 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.06 | 0.3 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |